journal article·2026-03-20Open access

Hyaluronic Acid as an Adjunctive Therapy in Periodontal and Dental Treatment of Medically Compromised Patients: A Narrative Review

Meizi Eliezer, Ruxandra Christodorescu, Alla Belova, Darian Rusu, Stefan Milicescu, Moshe Cohen, Stefan-Ioan Stratul

Abstract

Hyaluronic acid (HA) is a biologically active glycosaminoglycan with recognized roles in wound healing and inflammation modulation, and its adjunctive use in dental and periodontal therapy has gained interest, particularly in medically compromised patients. This narrative review critically evaluated preclinical and clinical evidence on locally applied HA in periodontal, oral surgical, peri-implant, and oral medicine treatments in patients with systemic conditions. A literature search of PubMed/MEDLINE, Scopus, and Web of Science (January 2015–December 2025) identified in vivo translational studies, randomized and controlled clinical trials, and selected systematic reviews involving medically compromised populations. Qualitative synthesis focused on biological plausibility, clinical outcomes, and safety. Nine core studies were included, comprising two preclinical in vivo investigations and seven clinical trials. In diabetic models, cross-linked high-molecular-weight HA reduced macrophage infiltration and delayed collagen membrane degradation without impairing angiogenesis. Clinically, adjunctive HA use in patients with type 2 diabetes mellitus was associated with modest but statistically significant short-term improvements in clinical attachment level (CAL) and enhanced early soft tissue healing following tooth extraction. In peri-implantitis therapy and oncology-related oral complications, HA application was linked to reduced inflammatory markers, decreased lesion severity, and improved patient-reported symptoms. No systemic adverse effects were reported. Overall, HA appears to be a locally safe adjunct that may support early healing and inflammation control in medically compromised patients, although its effects are primarily short-term and do not indicate disease-modifying potential.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Oral microbiology and periodontitis research · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University Clinic of Periodontology, Anton Sculean Research Center for Periodontal and Peri-Implant Diseases, Faculty of Dental Medicine, “Victor Babeș” University of Medicine and Pharmacy, Bulevardul Revoluției No. 9, 300041 Timișoara, Romania

Department V—Internal Medicine, Research Center—Institute of Cardiovascular Diseases, “Victor Babeș” University of Medicine and Pharmacy, Timișoara, Bulevardul Revoluției No. 12, 300024 Timișoara, Romania

Department of Dental Esthetics, Faculty of Dentistry, “Carol Davila” University of Medicine and Pharmacy, 9 Șoseaua Olteniței, Sector 4, 041292 Bucharest, Romania

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem ter 1, H-4032 Debrecen, Hungary

Funding

Victor Babes University of Medicine and Pharmacy Timisoara

References (38)

Show source-provided references
1. Hyaluronan: Its nature, distribution, functions and turnover10.1046/j.1365-2796.1997.00170.x ↗
2. Hyaluronan as an immune regulator in human diseases10.1152/physrev.00052.2009 ↗
3. Hyaluronan biology: A complex balancing act of structure, function, location and context10.1016/j.matbio.2019.02.002 ↗
4. Functions of hyaluronan in wound repair10.1046/j.1524-475X.1999.00079.x ↗
5. Hyaluronic acid to improve healing of surgical incisions in the oral cavity: A pilot multicentre placebo-controlled randomised clinical trial
6. Factors affecting wound healing10.1177/0022034509359125 ↗
7. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis10.1002/art.24925 ↗
8. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis10.1016/j.semarthrit.2015.04.011 ↗
9. Hyaluronic acid: A key molecule in skin aging10.4161/derm.21923 ↗
10. Effectiveness of hyaluronic acid for treating diabetic foot: A systematic review and meta-analysis10.1111/dth.12153 ↗
11. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled study10.1111/wrr.12428 ↗
12. Hyaluronic acid slows down collagen membrane degradation in uncontrolled diabetic rats10.1111/jre.12665 ↗
13. Cross-linked hyaluronic acid slows down collagen membrane resorption in diabetic rats through reducing the number of macrophages10.1007/s00784-021-04206-x ↗
14. Accelerated degradation of collagen membranes in diabetic rats is associated with increased infiltration of macrophages and blood vessels10.1007/s00784-015-1635-9 ↗
15. Opposing effects of diabetes and tetracycline on the degradation of collagen membranes in rats10.1902/jop.2012.120188 ↗
16. Periodontitis and diabetes: A two-way relationship10.1007/s00125-011-2342-y ↗
17. Diabetes mellitus and periodontitis: A tale of two common interrelated diseases10.1038/nrendo.2011.106 ↗
18. Diabetes and periodontal diseases: Consensus report of the 2013 International Workshop
19. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management10.1016/j.ctrv.2018.06.007 ↗
20. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop10.1002/JPER.17-0721 ↗
21. Diabetes and periodontal diseases: Consensus report10.1111/jcpe.12077 ↗
22. SANRA—A scale for the quality assessment of narrative review articles10.1186/s41073-019-0064-8 ↗
23. Effectiveness of 0.2% hyaluronic acid on clinical and microbiological parameters in type 2 diabetes mellitus patients with periodontitis10.1055/s-0044-1782188 ↗
24. Hyaluronic acid accelerates bone repair in human dental sockets: A randomized triple-blind clinical trial
25. The effect of hyaluronic acid addition to collagen in reducing trismus and swelling after extraction of impacted third molars: A randomized study10.1007/s00784-023-05092-1 ↗
26. Ruggiero, T., Carossa, M., Camisassa, D., Podda, D., Cama, G., Michieli, L., Bosio, D., Berrone, M., Mozzati, M., and Carossa, S. (2024). Hyaluronic acid treatment of post-extraction tooth socket healing in subjects with type 2 diabetes mellitus. J. Clin. Med., 13.10.3390/jcm13020452 ↗
27. Hyaluronic acid reduces inflammation and crevicular fluid IL-1β concentrations in peri-implantitis: A randomized controlled clinical trial10.5051/jpis.1903660183 ↗
28. Short-term effects of hyaluronic acid on the subgingival microbiome in peri-implantitis10.1002/JPER.19-0184 ↗
29. Treatment of symptomatic oral mucositis with sodium hyaluronate in HSCT patients
30. Agha-Hosseini, F., Pourmirzaiee, M., Mashayekhi, S., Sheykhbahaei, N., Amirchaghmaghi, M., Moosavi, M.S., and Mozafari, P.M. (2021). Mouthwash containing vitamin E, triamcinolone, and hyaluronic acid for radiotherapy-induced mucositis. Front. Oncol., 11.10.3389/fonc.2021.614877 ↗
31. Efficacy of Mucosamin Spray as an Adjunct for Prevention of Oral Mucositis in Children under Chemotherapy: A Two-Center Randomized Clinical Trial
32. Sodium-hyaluronate mouthwash on radiotherapy-induced xerostomia
33. Rojas, M.A., Marini, L., Sahrmann, P., and Pilloni, A. (2022). Hyaluronic acid as adjunct to coronally advanced flap procedures: A systematic review and meta-analysis. J. Pers. Med., 12.10.3390/jpm12091539 ↗
34. Hyaluronic acid as adjunctive to non-surgical and surgical periodontal therapy: A systematic review and meta-analysis10.1007/s00784-019-03012-w ↗
35. Activity of two hyaluronan preparations on primary human oral fibroblasts
36. Impact of defect configuration on regenerative therapy of peri-implantitis10.1111/j.1600-051X.2010.01540.x ↗
37. The pathobiology of mucositis10.1038/nrc1318 ↗
38. Mucositis: Pathobiology and management10.1097/CCO.0000000000000180 ↗